Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects (original) (raw)

Preexisting Immunity to Pandemic (H1N1) 2009

Zheng Xing

Emerging Infectious Diseases, 2009

View PDFchevron_right

Influenza A (H1N1) 2009: To vaccinate or not to vaccinate?

Sidgi Hasson

Sultan Qaboos University medical journal, 2009

View PDFchevron_right

Influenza Vaccination in 29 Countries

David Fedson

PharmacoEconomics, 1999

View PDFchevron_right

Influenza and Influenza Vaccine: A Review

Chelsea Carter

Journal of Midwifery & Women's Health, 2021

View PDFchevron_right

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

Daniela Toneatto

Vaccine, 2003

View PDFchevron_right

Influenza vaccines in low and middle income countries

Michiel de Boer

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality

Ivan Martinez

Medicine, 2015

View PDFchevron_right

The New Influenza A (H1N1) Pandemic

Ben Berkhout

Journal of the Formosan Medical Association, 2009

View PDFchevron_right

Re: Decreased Immune Responses to Influenza Vaccination in Patients With Heart Failure

Maryl Johnson

Journal of Cardiac Failure, 2009

View PDFchevron_right

Impact of the 2004 Influenza Vaccine Shortage on Patients from Inner City Health Centers

Edmund Ricci

Journal of Urban Health, 2007

View PDFchevron_right

Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles

Fu-Shi Quan

PLoS ONE, 2009

View PDFchevron_right

Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza

JENARO ASTRAY

Clinical Infectious Diseases, 2013

View PDFchevron_right

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults

Todd Hatchette

Human Vaccines & Immunotherapeutics, 2013

View PDFchevron_right

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012–2016

Mary Nowalk

Vaccine, 2018

View PDFchevron_right

Vaccines for preventing influenza in the elderly

Alessandro Rivetti

Reviews, 2006

View PDFchevron_right

Guillain-Barré Syndrome After Influenza Vaccination in Adults

Mawj Al Ani, MD

Archives of Internal Medicine, 2006

View PDFchevron_right

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials)

E. Grigor'eva

Influenza and Other Respiratory Viruses, 2008

View PDFchevron_right

Efficacy and Safety of 1 and 2 Doses of Live Attenuated Influenza Vaccine in Vaccine-Naive Children

Lucia Bricks

Pediatric Infectious Disease Journal, 2009

View PDFchevron_right

Annual influenza vaccination effect on the susceptibility to COVID-19 infection

Şemsi Karabela

Central European Journal of Public Health, 2021

View PDFchevron_right

2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

Mary Nowalk

Clinical Infectious Diseases, 2016

View PDFchevron_right

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

Phillip Berman

Journal of Infectious Diseases, 2012

View PDFchevron_right

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews

Lill Trogstad

Frontiers in Immunology, 2021

View PDFchevron_right

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

veronica diermayr

Vaccine, 2011

View PDFchevron_right

An evaluation of the emerging vaccines against influenza in children

Igor Rudan

BMC Public Health, 2013

View PDFchevron_right

Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older Adults

George Kuchel

Vaccines, 2021

View PDFchevron_right